BRUSSELS, Jan. 12 (Xinhua) -- The European Medicines Agency (EMA) said on Tuesday it had received the application for conditional marketing authorization for a COVID-19 vaccine developed by AstraZeneca and Oxford University, and it could make a recommendation by the end of January through an accelerated procedure.
EMA said in a statement that an opinion on the marketing authorization could be issued during a meeting of EMA's scientific committee for human medicines scheduled for Jan. 29.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!